ALLOY THERAPEUTICS UK LIMITED

Profile ALLOY THERAPEUTICS UK LIMITED

Actual on 01.07.2021
Company name
ALLOY THERAPEUTICS UK LIMITED
copy
copied
Company number
11870377
copy
copied
Company status
Active
copy
copied
Company type
Private Limited Company
copy
copied
Incorporated on
Friday, 08 March 2019
copy
copied
Accounts

Actual

First accounts made up to 31.12.2020 due by 30.09.2021

Last accounts made up to 31.12.2019

Confirmation statement

Actual

Next statement date Monday, 04 April 2022 due by Monday, 18 April 2022

Last statement dated Sunday, 04 April 2021

Nature of business (SIC)
72110 - Research and experimental development on biotechnology
copy
copied
Registered office address
UNIT 3 MCCLINTOCK BUILDING, GRANTA PARK, CAMBRIDGE, ENGLAND, GREAT ABINGTON, CB21 6GP
copy
copied

PSC and Officers ALLOY THERAPEUTICS UK LIMITED

Officers

(as of 24.09.2020)

ANDERSON, Errik
Status: Active
Appointed on: Friday, 08 March 2019
Correspondence address: 44 South Main Street, 2nd Floor Hanover, New Hampshire, United States, 03755
Nationality: American
Date of birth: March 1978
Role: Director
Occupation: Biotech Executive
Country of residence: United States
SNAITH, Richard Michael
Status: Active
Appointed on: Thursday, 09 May 2019
Correspondence address: Alloy Therapeutics Uk Limited Suite 3, Ground Floor, The Mccintock Building, Granta Park, Great Abington, United Kingdom, Cambridgeshire, CB21 6GP
Nationality: British
Date of birth: April 1969
Role: Director
Occupation: Director, Chief Scientific Officer
Country of residence: United Kingdom
SNYDER, Logan
Status: Active
Appointed on: Friday, 08 March 2019
Correspondence address: 44 South Main Street, 2nd Floor Hanover, New Hampshire, United States, 03755
Role: Secretary
Person with significant control

(as of 01.07.2021)

Errik Anderson
Status: Active
Notified on: Friday, 08 March 2019
Correspondence address: 44 South Main Street, 2nd Floor New Hampshire, United States
Nationality: American
Date of birth: March 1978
Legal form: Individual Person With Significant Control
Country of residence: United States
Nature of control:

Ownership Of Shares 75 To 100 Percent

Voting Rights 75 To 100 Percent

Right To Appoint And Remove Directors